Matrix metalloproteinase inhibition: A review of anti-tumour activity: Matrix metalloproteinase inhibition: A review of anti-tumour activity

Annals of Oncology

Volumn 6, Issue 10, 1995, Pages 967-974

  Brown, P D ^a   Giavazzi, R ^b  

^a British Biotech Pharmaceuticals Ltd   (United Kingdom)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Cancer therapy; Matrix metalloproteinases; Metastasis; Timp

Indexed keywords

BATIMASTAT; MARIMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PROTEINASE INHIBITOR; RECOMBINANT TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; HUMANS; MELANOMA, EXPERIMENTAL; METALLOENDOPEPTIDASES; NEOVASCULARIZATION, PATHOLOGIC; PHENYLALANINE; PROTEASE INHIBITORS; THIOPHENES;

EID: 0029586589     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a059091     Document Type: Review

References (48)

1. L.A. Liotta W.G. Stetler-Stevenson Principles of molecular cell biology of cancer: Cancer metastasis V.T. DeVita S. Hellman S.A. Rosenberg Jr Cancer Principles and Practice of Oncology (4th edition) 1993 JB Lippincott Philadelphia 134 140
2. L. Weiss Comments on hematogenous metastatic patterns in humans as revealed by autopsy Clin Exp Metastasis 10 1992 191 199
3. E.B. Springman E.L. Angleton H. Birkedal-Hansen Multiple modes of activation of latent human fibroblast collagenase Proc Natl Acad Sci USA 87 1990 364 368
4. D.E. Kleiner W.G. Stetler-Stevenson Structural biochemistry and activation of matrix metalloproteases Curr Op Cell Biol 5 1993 891 897
5. A.J.P. Docherty A. Lyons B.J. Smith Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity Nature 318 1985 66 69
6. W.G. Stetler-Stevenson H.C. Krutzsch L.A. Liotta Tissue inhibitor of metalloproteinase (TIMP-2) A new member of the metalloproteinase inhibitor family. J Biol Chem 264 29 1989 17374 17378
7. C.A. Brenner R.R. Adler D.A. Rappolee Genes for extracellular matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development Genes Dev 3 1989 848 859
8. E.C. Bullen M.T. Longaker D.L. Updike Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds J Invest Dermatol 104 1995 236 240
9. P.D. Brown R.E. Bloxidge N.S.A. Stuart Association between expression of activated 72-kilodalton gelatinase and rumour spread in non-small cell lung cancer J Natl Cancer Inst 85 1993 574 578
10. B. Davies D.W. Miles L.C. Happerfield Activity of type IV collagenases in benign and malignant breast disease Br J Cancer 67 1993 1126 1131
11. N. Smyth-Templeton P.D. Brown A.T. Levy Cloning and characterization of human melanoma interstitial collagenase Cancer Res 50 1990 5431 5437
12. P.D. Brown A.T. Levy I.M.K. Margulies Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines Cancer Res 50 1990 6184 6191
13. C. Monteagudo M.J. Merino J. San-Juan Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue Am J Pathol 136 1990 585 592
14. P. Basset J.P. Bellocq C. Wolf A novel metalloproteinase gene specifically expressed in stromal cell of breast carcinomas Nature 348 1990 699 704
15. K.J. Newell J.P. Witty W.H. Rodgers Expression and localisation of matrix-degrading metalloproteinases during colorectal tumorigenesis Mol Carcin 10 1994 199 206
16. R.E. Hewitt I.H. Leach D.G. Powe Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours Int J Cancer 49 1991 666 672
17. H. Sato T. Takino Y. Okada A matrix metalloproteinase expressed on the surface of invasive tumour cells Nature 370 1994 61 65
18. J. Cao H. Sato T. Takino The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation J Biol Chem 270 1995 801 805
19. M.R. Emmert-Buck M.J. Roth Z. Zhuang et al Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 145 1994 1285 1290
20. J. Folkman What is the evidence that rumors are angiogenesis dependent J Natl Cancer Inst 82 1990 4 6
21. N. Weidner J.P. Semple W.R. Welch Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma N Engl J Med 324 1991 1 8
22. P. Macchiarini G. Fontanini M.J. Hardin Relation of neovascularisation to metastasis of non-small cell lung cancer Lancet 340 1992 145 146
23. P. Mignatti R. Tsuboi E. Robbins In vitro angiogenesis on the human amniotic membrane: Requirement of basic fibroblast growth factor-induced proteinases J Cell Biol 108 1989 671 682
24. K. Darlak R.B. Miller M.S. Stack Thiol-based inhibitors of mammalian collagenase J Biol Chem 265 1990 5199 5205
25. W. Bode P. Reinemer R. Huber The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity EMBO J 13 1994 1263 1269
26. G. Murphy A. Houbrechts M.I. Cockett The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity Biochemistry 30 1991 8097 8101
27. R.G.S. Chirivi A. Garofalo M.J. Crimmin Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor Int J Cancer 58 1994 460 464
28. B. Davies P. Brown N. East A synthetic matrix metalloproteinase inhibitor decreases tumour burden and prolongs survival of mice bearing human ovarian carcinoma xenografts Cancer Res 53 1993 2087 2091
29. G. Taraboletti A. Garofalo D. Belotti Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases J Natl Cancer Inst 87 1995 293 298
30. A.N. Murphy E.J. Unsworth W.G. Stetler-Stevenson Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation J Cell Physiol 157 1993 351 358
31. A. Albini A. Melchiori S. Santi Tumour cell invasion inhibited by TIMP-2 J Natl Cancer Inst 83 1991 775 779
32. R.M. Schultz S. Silberman B. Persky Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonisation by murine B16-F10 melanoma cells Cancer Res 48 1988 5539 5545
33. O.A. Alvarez D.F. Carmichael Y.A. DeClerck Inhibition of collagenolytic activity and metastasis of tumour cells by a recombinant human tissue inhibitor of metalloproteinases J Natl Cancer Inst 82 1990 589 595
34. I.R. Hart The selection and characterisation of an invasive variant of B16 melanoma Am J Pathol 97 1979 587 600
35. R. Reich E.W. Thompson Y. Iwamoto Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells Cancer Res 48 1988 3307 3312
36. R. Khokha Suppression of the tumourigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of metalloproteinases-1 J Natl Cancer Inst 86 1994 299 304
37. Y.A. Declerck N. Perez H. Shimada Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases Cancer Res 52 1992 701 708
38. B.G. Ward K. Wallace J.H. Shephard Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice Cancer Res 47 1987 2662 2667
39. S.A. Watson T.M. Morris D.M. Crosbee A new hepatic invasive human colo-rectal xenograft model Eur J Cancer 29 1993 1740 1745
40. S.A. Watson T.M. Morris G. Robinson Inhibition of organ invasion by the matrix metalloproteinase inhibitor, batimastat (BB-94) in two human colorectal carcinoma metastasis models Cancer Res 1995
41. X. Wang X. Fu P.D. Brown Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumour growth and spread in a patient-like orthotopic model in nude mice Cancer Res 54 1994 4726 4728
42. R.L. Williams W. Risau H.G. Zerwes Endotheliomas expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment Cell 57 1989 1053 1063
43. M.A. Moses J. Sudhalter R. Langer Identification of an inhibitor of neovascularization from cartilage Science 248 1990 1408 1410
44. G.J. Beattie H.A. Young J.F. Smyth Phase I study of intra-peritoneal metalloproteinase inhibitor BB-94 in patients with malignant ascites Abstract presented at the 8th NCI-EORTC Symposium on New Drug Development 1994
45. V.M. Macaulay K.J. O’Byrne M.P. Saunders Phase I study of matrix metalloproteinase (MMP) inhibitor batimastat (BB-94) in patients with malignant pleural effusions Br J Cancer 71 Suppl XXIV 1995 11
46. A.H. Drummond P. Beckett E.A. Bone BB-2516: An orally bioavailable matrix metalloproteinase inhibitor with efficacy in animal cancer models Proc Am Assoc Cancer Res 36 1995 100
47. U. Sagman R. Feld W.K. Evans The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer J Clin Oncol 9 1991 954 961
48. B.A. Teicher S.A. Holden G. Ara Potentiation of cytotoxic cancer therapies by TNP-1470 alone and with other antiangiogenic agents Int J Cancer 57 1994 920 925